Zafirlukast Tablet, Film Coated
Product Images NDC 72162-2361

View Photos of Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 4 technical images submitted to the FDA as part of the official labeling for Zafirlukast (NDC 72162-2361). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Bryant Ranch Prepack, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Camber (Camber)

FDA Label Image

Label (Lbl721622361)

Label (Lbl721622361)
This is a description of the medication Zafirlukast, which comes in the form of film-coated tablets containing 20 mg of the active ingredient. The tablets are stored at 20° to 25°C (68° to 77°F) and should be protected from light and moisture. Patients can find more information on this medication at www.dailymed.nlm.nih.gov. It is advised to keep this medication out of the reach of children and dispense it in the original airtight container. The pharmaceutical company, Bryant Ranch Prepack, Inc., relabeled the medication which is manufactured by Annora Pharma Pvt Ltd. The usual dosage information can be found in the prescribing information available at www.dailymed.nim.nih.gov.*
FDA Label Image

Zafirlukastfig (Zafirlukastfig)

Zafirlukastfig (Zafirlukastfig)
This unavailable.*
FDA Label Image

Zafirlukaststructure (Zafirlukaststructure)

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.